Named Lecture:
92. John F. Enders Lecture
Friday, October 21, 2011: 5:30 PM-6:15 PM
Room: Grand Ballroom (East-West)

Learning Objectives:

At the conclusion of this session, participants will be able to: 

  • review major advances in molecular diagnostics as applied to viral pathogens
  • summarize the strengths and limitations of molecular approaches
  • describe how test performance characteristics impact their interpretation and clinical management decisions 

Target Audience: Vaccinologists, Scientists, Researchers, Public Health Practitioners, Pharmacists, Nurses, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, Hospital Administrators, HIV Specialists, HIV Clinicians, Health Care Workers, Fellows-in-Training, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Global ID, Investigative ID, HIV, Pediatric ID, Adult ID

Moderator:  Barbara D. Alexander, MD, FIDSA, Duke University

Presentations:

5:30 PM
787

CME Credits: Maximum of 0.75 hours of Category 1 credit possible

ACPE Credits: ACPE 0.75 knowledge-based contact hours (0.075 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-102-L01-P

Disclosures:

B. D. Alexander, None

A. Caliendo, Roche Diagnostics: Scientific Advisor, Consulting fee
Abbott Diagnostics: Scientific Advisor, Consulting fee
GenProbe: Scientific Advisor, Consulting fee
Quidel: Scientific Advisor, Consulting fee
Idaho Technologies: Scientific Advisor, Consulting fee
Biotrin: Consultant, Consulting fee
Roche Molecular: Investigator, Research support
Qiagen: Investigator, Research support

See more of: Named Lecture

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.